Journal
MOLECULAR GENETICS AND METABOLISM
Volume 132, Issue 2, Pages 86-93Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ymgme.2020.10.006
Keywords
Anderson-Fabry disease; Fabry nephropathy; Biomarkers; Clinical proteomics; Mass spectrometry; Matrix-assisted laser desorption/ionization
Ask authors/readers for more resources
Nephropathy is a major complication of Fabry Disease, and accurate characterization of it is crucial for predicting disease progression and assessing therapeutic responses. Proteomics offers a sensitive and fast method to detect specific pathological proteins, discover diagnostic and prognostic biomarkers reflecting disease progression, and facilitate the evaluation of therapeutic responses.
Nephropathy represents a major complication of Fabry Disease and its accurate characterization is of paramount importance in predicting the disease progression and assessing the therapeutic responses. The diagnostic process still relies on performing renal biopsy, nevertheless many efforts have been made to discover early reliable biomarkers allowing us to avoid invasive procedures. In this field, proteomics offers a sensitive and fast method leading to an accurate detection of specific pathological proteins and the discovery of diagnostic and prognostic biomarkers that reflect disease progression and facilitate the evaluation of therapeutic responses. Here, we report a review of selected literature focusing on the investigation of several proteomic techniques highlighting their advantages, limitations and future perspectives in their application in the routine study of Fabry Nephropathy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available